SAN DIEGO , Aug. 28, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian , Ph.
D., will be the featured speaker in a fireside chat at the Morgan Stanley 22 nd Annual Global Healthcare Conference. The conference will take place September 4-6, 2024 , in New York City .
Details are as follows: Morgan Stanley 22 nd Annual Global Healthcare Conference Details: Dr. Lian will participate in a fireside chat and in 1-on-1 meetings Conference dates: September 4-6, 2024 Fireside Chat Timing: 1:50 – 2:25 p.m.
Eastern on Wednesday, September 4, 2024 Location: New York Marriott Marquis A live webcast of the fireside chat may be accessed via a link on the Viking Therapeutics website in the Investors & Media section under Webcasts . Additionally, a replay of the webcast will be available on the Viking website following the conference. About Viking Therapeutics, Inc.
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders, with three compounds currently in clinical trials. Viking's research and development activities leverage its expertise in metabolism to develop innovative therapeutics designed to improve patients' lives.
Viking's clin.